Advances in understanding the pathogenesis of primary familial and congenital polycythaemia

46Citations
Citations of this article
42Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Primary familial and congenital polycythemia (PFCP) is an autosomal-dominant proliferative disorder characterized by erythrocytosis and hypersensitivity of erythroid progenitors to erythropoietin (Epo). Several lines of evidence suggest a causal role of truncated erythropoietin receptor (EpoR) in this disease. In this review, we discuss PFCP in the context of erythrocytosis and EpoR signalling. We focus on recent studies describing mechanisms underlying Epo-dependent EpoR down-regulation. One mechanism depends on internalization mediated through the p85 regulatory subunit of the Phosphoinositide 3-Kinase, and the other utilizes ubiquitin-based proteasomal degradation. Truncated PFCP EpoRs are not properly down-regulated upon stimulation, underscoring the importance of these mechanisms in the pathogenesis of PFCP. © 2010 Blackwell Publishing Ltd.

Cite

CITATION STYLE

APA

Huang, L. J., Shen, Y. M., & Bulut, G. B. (2010). Advances in understanding the pathogenesis of primary familial and congenital polycythaemia. British Journal of Haematology. Blackwell Publishing Ltd. https://doi.org/10.1111/j.1365-2141.2009.08069.x

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free